Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
Clicks: 164
ID: 102174
2020
| Reference Key |
lee2020relativezeitschrift
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lee, Y.H. |
| Journal | Zeitschrift für Rheumatologie |
| Year | 2020 |
| DOI | 10.1007/s00393-020-00750-1 |
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.